-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Baricitinib is sold under brands such as Olumiant.
Rheumatoid Arthritis FDA
Eli Lilly and partner Incyte revealed that their JAK inhibitor Olumiant maintains consistent safety in long-term analysis of patients with rheumatoid arthritis (RA)
These patients received a total of 14,744 patient-years of treatment.
In 14,744 patient-year exposures, the incidence rate remained stable over time, and the incidence of serious infections was found to be 2.
thrombusHeart blood vessels
Peter C.
Original source:
Original source:https:// href="https://" target="_blank" rel="noopener">https:// https://